Response to Induction Chemotherapy Predicts Survival in AML: A Single Centre Experience from North India
Journal Title: Indian Journal of Cancer Education and Research - Year 2018, Vol 6, Issue 2
Abstract
Aim: The present study was carried out to analyze the various patient related (e.g. age, sex, performance status), disease related (white blood cell count, cytogenetic and molecular mutational status)and treatment related (delay in treatment initiation and response to induction chemotherapy)variables as predictors of outcome in acute myeloid leukemia (AML) patients presenting to a tertiary care center in North India. Materials and Methods: Thedata of all newly diagnosed de-novo AML patients who presented to our center from January 2015 to December 2017 and opted for chemotherapy was correlated with treatment outcome. Results: Sixty eight patients underwent induction chemotherapy during the study period. Sixteen (23.5%), 49 (72.1%) and 3 (4.4%) were in the favorable, intermediate and adverse risk groups, respectively. Fifteen (22%), 8 (11.7%) and 11 (16.1%) patients were positive for AML-ETO, NPM1, FLT3 mutations (3 patients had FLT3 D835 mutations), respectively. Exon 17 c-kit mutations were seen in 10 (14.7%) patients. We did not observe any exon 8 c-kit mutations in our cohort of patients. Biallelic CEBPA mutations were seen in 6 patients (8.8%). Following induction chemotherapy, 26 (38.2%) patients attained complete remission (CR), 20 (29.4%) achieved incomplete CR (platelet count<100 x 109/L) and 22 (32.4%) were refractory to induction therapy. There were only 3 (4.4%) induction deaths.High TLC was associated with FLT3 mutations (p=0.03) and presence of extra medullary disease correlated with AML-ETO (p=0.02) and c-KIT mutations (p=0.02). There was statistically significant correlation of FLT3-ITD mutation positive patients with risk of relapse (p= 0.001). The 2 yr Overall survival (OS) and Event free survival (EFS) were 39.6% and 22.8%, respectively. In a multivariate analysis, the performance status (PS) and post induction remission status independently predicted survival. Conclusion: Thus our data highlights that PS and post induction remission status translates into better OS.
Authors and Affiliations
Anshul Gupta
Keywords
Related Articles
- EP ID EP569258
- DOI 10.21088/ijcer.2321.9815.6218.2
- Views 63
- Downloads 0
Cytological Grading of Breast Carcinoma on FNAC & Correlation with Histological Grading on Excised Specimen
Background: With the advent of fine needle aspiration cytology (FNAC), the approach to diagnosis and management of breast lesions has been revolutionized. Assigning a tumor grade to breast cancer provides important progn...
Daily Online Cone Beam Computed Tomography (CBCT) to Assess Interfractional Motion in Patients with Intact Cervical Carcinoma Treated with Volumetric Modulated ARC Therapy (VMAT)
Aim: To analyse and correct interfractional set up error in cervical carcinoma patients with intact cervix, treated with VMAT technique through daily online kilo voltage cone beam CT. Materials and Methods: The presen...
Evaluation of Changes in Pulmonary Function in Concurrent Chemoradiation in Non Small Cell Lung Cancer
Aim: To evaluate the changes in pulmonary function with concurrent chemoradiation. Materials and Methods: We analyzed 60 patients who had received 60 Gy radiotherapy, chemotherapy for primary NSCLC who had undergone pul...
Sebaceous Gland Carcinoma of Upper Eyelid with Parotid Metastasis: A Case Report
Sebaceous gland carcinoma is a rare malignancy which usually arises from periocular region. It accounts of 1–5.5% eyelid malignancies and represents third most common eyelid malignancy. It mostly occurs in elderly women...
Pathological Response in Assessment of Neo-Adjuvant Chemo Radiotherapy in Locally Advanced in Carcinoma of Rectum
Aim: To assess the toxicity differences between neo adjuvant and adjuvant chemo radiation in carcinoma rectum. Materials and Methods: Patients who underwent neoadjuvant or adjuvant chemoradiation for carcinoma rectum wer...